These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9753062)

  • 1. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.
    Molldrem JJ; Jiang YZ; Stetler-Stevenson M; Mavroudis D; Hensel N; Barrett AJ
    Br J Haematol; 1998 Sep; 102(5):1314-22. PubMed ID: 9753062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.
    Laver J; Castro-Malaspina H; Kernan NA; Levick J; Evans RL; O'Reilly RJ; Moore MA
    Br J Haematol; 1988 Aug; 69(4):545-50. PubMed ID: 3136795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia.
    Killick SB; Marsh JC; Gordon-Smith EC; Sorlin L; Gibson FM
    Br J Haematol; 2000 Mar; 108(3):582-91. PubMed ID: 10759717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
    Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
    Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
    Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
    Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression.
    Kochenderfer JN; Kobayashi S; Wieder ED; Su C; Molldrem JJ
    Blood; 2002 Nov; 100(10):3639-45. PubMed ID: 12393644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
    Aivado M; Rong A; Stadler M; Germing U; Giagounidis A; Strupp C; Novotny J; Josten KM; Kobbe G; Hildebrandt B; Gattermann N; Aul C; Haas R; Ganser A
    Eur J Haematol; 2002 Apr; 68(4):210-6. PubMed ID: 12071936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antithymocyte globulin for human bone marrow transplantation. Antihematopoietic and immunosuppressive activity.
    Harada M; Gale RP
    Transplantation; 1982 Jun; 33(6):625-30. PubMed ID: 7048664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable TNF-alpha, IFN-gamma and GM-CSF production by purified normal marrow CD3 cells in response to horse anti-lymphocyte and rabbit antithymocyte globulin.
    Piaggio G; Podestá M; Pitto A; Pittaluga GB; Isaza A; Benvenuto F; Bruno B; Bacigalupo A
    Eur J Haematol; 1998 Apr; 60(4):240-4. PubMed ID: 9579877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.
    Amare M; Abdou NL; Robinson MG; Abdou NI
    Am J Hematol; 1978; 5(1):25-32. PubMed ID: 311583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antithymocyte globulin on natural killer cells.
    Neudorf S; Jones M
    Exp Hematol; 1988 Nov; 16(10):831-5. PubMed ID: 3139435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism.
    Teramura M; Kobayashi S; Iwabe K; Yoshinaga K; Mizoguchi H
    Br J Haematol; 1997 Jan; 96(1):80-4. PubMed ID: 9012691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia.
    Platanias L; Gascon P; Bielory L; Griffith P; Nienhuis A; Young N
    Br J Haematol; 1987 Aug; 66(4):437-43. PubMed ID: 3117088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
    Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
    Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
    Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
    Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2.
    Burdach S; Shatsky M; Wagenhorst B; Levitt L
    J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive treatment of the myelodysplastic syndrome].
    Larsen MS; Hasselbalch HC
    Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: correlation with in vitro erythroid culture studies.
    Mangan KF; Shadduck RK
    Am J Hematol; 1984; 17(4):417-26. PubMed ID: 6238526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.